ADIPOQ and metabolic syndrome: Despite the fact that adiponectin and leptin were independently associated with the development of metabolic syndrome (MS), diabetes mellitus (DM) type II and cardiovascular diseases, the ratio adiponectin/leptin (A/L) showed a stronger association with these pathological conditions than individual hormones [8].